Web-based references relating to the number under the disk sign, listed by page header
Hereditary haemachromotosis (HH)
77 Calculation and interpretation of the hepatic
iron index: A brief summary--Michael Torbenson, M.D., Michael Nalesnik, M.D. and
Robert Bourne
[Link]
; page 254
78 Osteoporosis in hemochromatosis: iron excess,
gonadal deficiency, or other factors? Author: Diamond T, Stiel D, Posen S.
Journal: Ann Intern Med; 1989 Mar 15 ; 110(6):430-6. PubMed ID: 2919850.
[Link]
; page 254
79 Mineralocorticoid status and endocrine
dysfunction in severe hemochromatosis. Author: Hempenius LM, Van Dam PS, Marx
JJ, Koppeschaar HP. Journal: J Endocrinol Invest; 1999 May ; 22(5):369-76.
PubMed ID: 10401711.
[Link]
; page 254
80 Assessment of hepatic iron content using
magnetic resonance imaging. Author: Li TQ, Aisen AM, Hindmarsh T. Journal: Acta
Radiol; 2004 Apr ; 45(2):119-29. PubMed ID: 15191093.
[Link]
; page 254
81 No link available
82 Primary liver cancer
and survival in patients undergoing liver transplantation for hemochromatosis.
Author: Kowdley KV, Hassanein T, Kaur S, Farrell FJ, Van Thiel DH, Keeffe EB,
Sorrell MF, Bacon BR, Weber FL, Tavill AS. Journal: Liver Transpl Surg; 1995 Jul
; 1(4):237-41. PubMed ID: 9346573.
[Link]
; page 254
83 Prognostic factors for hepatocellular
carcinoma in genetic hemochromatosis. Author: Fargion S, Fracanzani AL, Piperno
A, Braga M, D'Alba R, Ronchi G, Fiorelli G. Journal: Hepatology; 1994 Dec ;
20(6):1426-31. PubMed ID: 7982640.
[Link]
; page 254
84 [Successful treatment using iron depletion
phlebotomy combined with recombinant erythropoietin after allogeneic bone marrow
transplantation for myelodysplastic syndrome complicated by secondary
hemochromatosis] Author: Shinjo K, Takeshita A, Naito K, Ohnishi K, Hirabayashi
N, Ohno R. Journal: Rinsho Ketsueki; 2001 Jul ; 42(7):571-4. PubMed ID:
11524849.
[Link]
; page 254
(footnote) Hepatic
iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays
for the diagnosis of hereditary hemochromatosis. Author: Press RD, Flora K,
Gross C, Rabkin JM, Corless CL. Journal: Am J Clin Pathol; 1998 May ;
109(5):577-84. PubMed ID: 9576576.
[Link]; page 254
(footnote)
[Link]; page 254
(footnote) Utility
of hepatic iron index in American patients with hereditary hemochromatosis: a
multicenter study. Author: Kowdley KV, Trainer TD, Saltzman JR, Pedrosa M,
Krawitt EL, Knox TA, Susskind K, Pratt D, Bonkovsky HL, Grace ND, Kaplan MM.
Journal: Gastroenterology; 1997 Oct ; 113(4):1270-7. PubMed ID: 9322522.
[Link]; page 254
85 No link available
86 Milestones in
transplantation
[Link]
; page 255
87; page Int J Colorectal Dis. 2002 Nov;17(6):402
Improvement in irritable bowel syndrome following ano-rectal surgery--Palmer BV
[Link]
; page 255
88 Graft-versus-host disease following living
donor liver transplantation. Author: Soejima Y, Shimada M, Suehiro T, Hiroshige
S, Gondo H, Takami A, Yasue S, Maehara Y. Journal: Liver Transpl; 2004 Mar ;
10(3):460-4. PubMed ID: 15004778.
[Link]
; page 255
89 Pretransplant renal dysfunction predicts
poorer outcome in liver transplantation. Author: Lafayette RA, Par", Schmid
CH, King AJ, Rohrer RJ, Nasraway SA. Journal: Clin Nephrol; 1997 Sep ;
48(3):159-64. PubMed ID: 9342487.
[Link]
; page 255
(footnote) Impact
of MELD on short-term and long-term outcome following liver transplantation: a
European perspective. Author: Nagler E, Vlierberghe HV, Colle I, Troisi R,
Hemptinne B. Journal: Eur J Gastroenterol Hepatol; 2005 Aug ; 17(8):849-56.
PubMed ID: 16003135.
[Link]; page 255
Alpha1- antitrypsin deficiency
90 No link available
91 Predictors of
mortality in alpha1-antitrypsin deficiency. Author: Dawkins PA, Dowson LJ, Guest
PJ, Stockley RA. Journal: Thorax; 2003 Dec ; 58(12):1020-6. PubMed ID: 14645964.
[Link]
; page 256
92 Factors associated with advanced liver disease
in adults with alpha1-antitrypsin deficiency. Author: Bowlus CL, Willner I, Zern
MA, Reuben A, Chen P, Holladay B, Xie L, Woolson RF, Strange C. Journal: Clin
Gastroenterol Hepatol; 2005 Apr ; 3(4):390-6. PubMed ID: 15822045.
[Link]
; page 256
(footnote) Tailored
pharmacokinetic dosing allows self-administration and reduces the cost of IV
augmentation therapy with human alpha(1)-antitrypsin. Author: Piitulainen E,
Bernsp" E, Bj"rkman S, Berntorp E. Journal: Eur J Clin Pharmacol; 2003 Jun ;
59(2):151-6. PubMed ID: 12728289.
[Link]; page 256
93 [Wilson's disease: a clinical case is
presented with neuropsychiatric dominant form and probable physiopathology
interpretation with magnetic resonance of the brain] Author: Casta"eda-Reyna MA,
Ubilluz R, Avalos C, Escalante D. Journal: Rev Neurol; 2002 Apr 16-30 ;
34(8):745-50. PubMed ID: 12080495.
[Link]
; page 257
94 Prognostic factors in patients presenting with
severe neurological forms of Wilson's disease. Author: Prashanth LK, Taly AB,
Sinha S, Ravishankar S, Arunodaya GR, Vasudev MK, Swamy HS. Journal: QJM; 2005
Aug ; 98(8):557-63. PubMed ID: 16006499.
[Link]
; page 257
Primary billary cirrhosis (PBC)
95 Ursodeoxycholic acid for primary biliary
cirrhosis. Author: Gluud C, Christensen E. Journal: Cochrane Database Syst Rev;
2002 ; (1):CD000551. PubMed ID: 11869580.
[Link]
; page 258
96 No link available; page 258
97 Sclerosing
cholangitis. Author: MacFaul GR, Chapman RW. Journal: Curr Opin Gastroenterol;
2004 May ; 20(3):275-80. PubMed ID: 15703653.
[Link]
; page 258
98 Bile acids for primary sclerosing cholangitis.
Author: Chen W, Gluud C. Journal: Cochrane Database Syst Rev; 2003 ;
(2):CD003626. PubMed ID: 12804480.
[Link]
; page 259
99 No link available; page 259
(footnote) PSC-IBD:
a unique form of inflammatory bowel disease associated with primary sclerosing
cholangitis. Author: Loftus EV, Harewood GC, Loftus CG, Tremaine WJ, Harmsen WS,
Zinsmeister AR, Jewell DA, Sandborn WJ. Journal: Gut; 2005 Jan ; 54(1):91-6.
PubMed ID: 15591511.
[Link]; page 259
(footnote) The
hepatitic/cholestatic; page 259
Autoimmune hepatitis
100 Overlap
syndromes of autoimmune hepatitis: what is known so far. Author: Durazzo M,
Premoli A, Fagoonee S, Pellicano R. Journal: Dig Dis Sci; 2003 Mar ;
48(3):423-30. PubMed ID: 12757152.
[Link]
; page 260
101 Treatment of autoimmune hepatitis. Author:
Czaja AJ. Journal: Semin Liver Dis; 2002 Nov; 22(4):365-78. PubMed ID: 12447708.
[Link]
; page 260
102 Review article: immunopathogenetic and
therapeutic aspects of autoimmune hepatitis. Author: Medina J, GarcBuey L,
Moreno-Otero R. Journal: Aliment Pharmacol Ther; 2003 Jan ; 17(1):1-16. PubMed
ID: 12492728.
[Link]
; page 260
103 Autoimmune hepatitis: effect of symptoms and
cirrhosis on natural history and outcome. Author: Feld JJ, Dinh H, Arenovich T,
Marcus VA, Wanless IR, Heathcote EJ. Journal: Hepatology; 2005 Jul ;
42(1):53-62. PubMed ID: 15954109.
[Link]
; page 260
(footnote) Autoimmune Hepatitis: Revised Scoring System
(1999)
[Link]; page 260
(footnote) Possible
pathomechanism of autoimmune hepatitis. Author: Prandota J. Journal: Am J Ther;
2003 Jan-Feb ; 10(1):51-7. PubMed ID: 12522521.
[Link]; page 260
104 Smooth muscle antibodies and type 1
autoimmune hepatitis. Author: Muratori P, Muratori L, Agostinelli D, Pappas G,
Veronesi L, Granito A, Cassani F, Terlizzi P, Lenzi M, Bianchi FB. Journal:
Autoimmunity; 2002 Dec ; 35(8):497-500. PubMed ID: 12765475.
[Link]
; page 261
